SST and neoplasm: Direct targeting of tumor cells is possible by the delivery of the high energy of the β emitter, lutetium, by internalization and storage within lysosomes.14PRRNT, along with somatostatin analogs, has proven its efficacy in treating gastroenteropancreatic NETs, which are somatostatin receptor positive.